Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/26 16:15 | 7/21/26 | OKYO | Health | BioPrd | Biological Products, (No Diag | Brancaccio John P | D | 1 | P.a | 7 | 1.48 | 0 | 5 | 17 | 35 | D | ||||||||||||||||
8/7/26 16:15 | 7/22/26 | OKYO | Health | BioPrd | Biological Products, (No Diag | Dempsey Robert John | DO | CEO | 1 | P.a | 23 | 1.54 | 0 | 15 | 15 | D | ||||||||||||||||
8/7/26 16:15 | 7/21/26 | OKYO | Health | BioPrd | Biological Products, (No Diag | Jacob Gary S | DO | CHIEF DE | 1 | P.a | 5 | 1.40 | 0 | 4 | 3 | 112 | D | |||||||||||||||
8/7/26 16:15 | 7/20/26 | OKYO | Health | BioPrd | Biological Products, (No Diag | Cerrone Gabriele M | DT | 2 | P.a | 68 | 1.42 | 0 | 48 | 0 | 10,874 | I | ||||||||||||||||
8/7/26 16:15 | 7/21/26 | OKYO | Health | BioPrd | Biological Products, (No Diag | Mantelli Flavio | O | CHIEF ME | 1 | P.a | 28 | 1.40 | 0 | 20 | 20 | D | ||||||||||||||||
8/7/26 16:15 | 7/27/26 | OKYO | Health | BioPrd | Biological Products, (No Diag | Patil Rajkumar V. | O | Chief Sc | 1 | P.a | 5 | 1.49 | 0 | 3 | 20 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |